Abstract
Introduction
We sought to determine the influence of primary tumor histology and metastatic tumor location on the frequency of seizures among patients with brain metastases. A secondary aim was to determine if surgery reduced the occurrence and frequency of seizures.
Methods
We retrospectively reviewed patients with cerebral metastasis at a single institution from 2006 to 2016.
Results
Among 1949 patients identified as having had cerebral metastasis, 168 (8.6%) had documentation of one or more seizures. The incidence of seizures was highest among patients with metastases from melanoma (19.8%), followed by those with colon cancer (9.7%), renal cell carcinoma (RCC; 8.3%), and lung cancer (7.0%). Among 1581 patients with melanoma, colon cancer, RCC, non-small cell lung cancer, or breast cancer, having metastases in the frontal lobe seemed to confer the greatest risk of seizures (n = 100), followed by foci in the temporal lobe (n = 20) and elsewhere (n = 16).
Conclusion
Patients with cerebral metastasis are at increased risk for seizures. Seizure rates seem to be higher for certain primary tumors, such as melanoma, colon cancer, and RCC, and for lesions located in the frontal lobe.
Similar content being viewed by others
References
Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L et al (2019) Brain metastases Nat Rev Dis Primers 5(1):5. https://doi.org/10.1038/s41572-018-0055-y
Rick JW, Shahin M, Chandra A, Dalle Ore C, Yue JK, Nguyen A et al (2019) Systemic therapy for brain metastases. Crit Rev Oncol Hematol 142:44–50. https://doi.org/10.1016/j.critrevonc.2019.07.012
Vogelbaum MA, Brown PD, Messersmith H, Brastionos PK, Burri S, Cahill D et al (2022) Treatment for brain metastasis: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492–516. https://doi.org/10.1200/JCO.21.02314
Killock D (2020) ICI for resected stage IV melanoma. Nat Rev Clin Oncol 17(8):450. https://doi.org/10.1038/s41571-020-0397-8
Rudà R, Mo F, Pellerino A (2020) Epilepsy in brain metastasis: an emerging entity. Curr Treat Options in Neurol 22(2):6. https://doi.org/10.1007/s11940-020-0613-y
Wolpert F, Lareida A, Terziev R, Grossenbacher B, Neidert MC, Roth P et al (2020) Risk factors for the development of epilepsy in patients with brain metastases. Neuro Oncol 22(5):718–728. https://doi.org/10.1093/neuonc/noz172
Chan V, Sahgal A, Egeto P, Schweizer T, Das S (2017) Incidence of seizure in adult patients with intracranial metastatic disease. J Neurooncol 131(3):619–624. https://doi.org/10.1007/s11060-016-2335-2
Maschio M (2012) Brain tumor-related epilepsy. Curr Neuropharmacol 10(2):124–133. https://doi.org/10.2174/157015912800604470
Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, Wilkens JA (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109(7):634–638. https://doi.org/10.1016/j.clineuro.2007.05.017
Wu A, Weingart JD, Gallia GL, Lim M, Brem H, Bettegowda C, Chaichana KL (2017) Risk factors for preoperative seizures and loss of seizure control in patients undergoing surgery for metastatic brain tumors. World Neurosurg 104:120–128. https://doi.org/10.1016/j.wneu.2017.05.028
Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wien Klin Wochenschr 114(21–22):911–916 (article in German)
Englot DJ, Chang EF, Vecht CJ (2016) Epilepsy and brain tumors. Handb Clin Neurol 134:267–285. https://doi.org/10.1016/B978-0-12-802997-8.00016-5
Rudà R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611–620. https://doi.org/10.1097/CCO.0b013e32833de99d
Ajinkya S, Fox J, Houston P, Greenblatt A, Lekoubou A, Lindhorst S, Cachia D, Olar A, Kutluay E (2021) Seizures in patients with metastatic brain tumors: Prevalence, clinical characteristics, and features on EEG. J Clin Neurophysiol 38(2):143–148. https://doi.org/10.1097/WNP.0000000000000671
Goldlust S, Hsu M, Lassman A, Panageas K, Avila E (2012) Seizure prophylaxis and melanoma brain metastases. J Neurooncol 108(1):109–114. https://doi.org/10.1007/s11060-012-0802-y
Lamba N, Catalano PJ, Cagney DN, Haas-Kogan DA, Bubrick EJ, Wen PY, Aizer AA (2021) Seizures among patients with brain metastases: a population-and institutional-level analysis. Neurology 96(8):e1237–e1250. https://doi.org/10.1212/WNL.0000000000011459
Berto P (2002) Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 20(15):1039–1059. https://doi.org/10.2165/00019053-200220150-00002
Soffietti R, Rudà R, Mutani R (2002) Management of brain metastases. J Neurol 249(10):1357–1369. https://doi.org/10.1007/s00415-002-0870-6
Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G (2002) Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96(3):552–558. https://doi.org/10.3171/jns.2002.96.3.0552
Van Vliet EA, da Costa AS, Redeker S, Van Schaik R, Aronica E, Gorter J (2007) Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130(2):521–534. https://doi.org/10.1093/brain/awl318
Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A (2007) TGF-β receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130(2):535–547. https://doi.org/10.1093/brain/awl317
Jung M, Ahn JB, Chang JH, Suh CO, Hong S, Roh JK, Shin SJ, Rha SY (2011) Brain metastases from colorectal carcinoma: prognostic factors and outcome. J Neurooncol 101(1):49–55. https://doi.org/10.1007/s11060-010-0214-9
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872. https://doi.org/10.1200/JCO.2004.12.149
Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10):2698–2705. https://doi.org/10.1002/cncr.10541
Koo T, Kim K, Park HJ, Han SW, Kim TY, Jeong SY, Park KJ, Chie EK (2020) Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: Multicenter retrospective study. Sci Rep 10(1):4340. https://doi.org/10.1038/s41598-020-61354-y
Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD, Pipas JM (2009) Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer 8(2):100–105. https://doi.org/10.3816/CCC.2009.n.016
de Groot M, Reijneveld JC, Aronica E, Heimans JJ (2012) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135(4):1002–1016. https://doi.org/10.1093/brain/awr310
Zaatreh MM, Spencer DD, Thompson JL, Blumenfeld H, Novotny EJ, Mattson RH, Spencer SS (2002) Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome. Epilepsia 43(7):727–733. https://doi.org/10.1046/j.1528-1157.2002.39501.x
Garcia JH, Morshed RA, Chung J, Chavez MAM, Sudhakar V, Saggi S et al (2022) Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases. J Neurosurg 138(1):19–26. https://doi.org/10.3171/2022.3.JNS212285
Bagla R, Skidmore CT (2011) Frontal lobe seizures. Neurologist 17(3):125–135. https://doi.org/10.1097/NRL.0b013e31821733db
Urban H, Willems LM, Ronellenfitsch MW, Rosenow F, Steinbach JP, Strzelczyk A (2020) Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition. OncoImmunology 9:1. https://doi.org/10.1080/2162402X.2020.1851517
Acknowledgements
The authors thank Christine F. Wogan, MS, ELS, of the Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center, for editorial assistance.
Funding
None/Not applicable.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The study protocol was approved by the Institutional Review Board.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huntoon, K., Musgrave, N., Shaikhouni, A. et al. Frequency of seizures in patients with metastatic brain tumors. Neurol Sci 44, 2501–2507 (2023). https://doi.org/10.1007/s10072-023-06695-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-06695-y